股本结构
单位：万股
| 公告日期 | 2026-05-06 | 2026-04-22 | 2026-04-22 | 2026-02-18 | 2026-02-25 | 2025-11-04 |
|---|---|---|---|---|---|---|
| 证券总股本 | 1668.38 | 1665.98 | 1660.60 | 41486.98 | 41472.80 | 41458.16 |
| 普通股本 | 1668.38 | 1665.98 | 1660.60 | 41486.98 | 41472.80 | 41458.16 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-04-30 | 2026-04-08 | 2026-03-31 | 2026-02-17 | 2025-12-31 | 2025-10-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-05-06 | 1668.38 | 未披露 | 定期报告 | 2026-04-30 |
| 2026-04-22 | 1665.98 | 未披露 | 定期报告 | 2026-04-08 |
| 2026-04-22 | 1660.60 | 未披露 |
更多>>
a 1-for-25 reverse stock split of the Company's common stock
|
2026-03-31 |
| 2026-02-18 | 41486.98 | 未披露 | 定期报告 | 2026-02-17 |
| 2026-02-25 | 41472.80 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2025-12-31 |
| 2025-11-04 | 41458.16 | 未披露 | 定期报告 | 2025-10-30 |
| 2025-11-04 | 41457.00 | 未披露 |
更多>>
From July 1, 2025 to September 30, 2025
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2025-09-30 |
| 2025-08-04 | 41442.31 | 未披露 | 定期报告 | 2025-07-31 |
| 2025-08-04 | 41428.30 | 未披露 |
更多>>
From April 1, 2025 to June 30, 2025
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2025-06-30 |
| 2025-05-06 | 41395.18 | 未披露 | 定期报告 | 2025-05-02 |
| 2025-05-06 | 41302.30 | 未披露 |
更多>>
From January 1, 2025 to March 31, 2025
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2025-03-31 |
| 2025-02-25 | 41230.31 | 未披露 | 定期报告 | 2025-02-21 |
| 2025-02-25 | 41219.40 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
Issuance of common stock
|
2024-12-31 |
| 2024-11-07 | 41201.78 | 未披露 | 定期报告 | 2024-11-01 |
| 2024-11-07 | 41196.00 | 未披露 |
更多>>
From July 1, 2024 to September 30, 2024
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2024-09-30 |
| 2024-08-06 | 41148.28 | 未披露 | 定期报告 | 2024-08-01 |
| 2024-08-06 | 41144.70 | 未披露 |
更多>>
From April 1, 2024 to June 30, 2024
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2024-06-30 |
| 2024-05-07 | 41126.16 | 未披露 | 定期报告 | 2024-05-01 |
| 2024-04-18 | 41105.71 | 未披露 | 定期报告 | 2024-04-04 |
| 2024-05-07 | 41084.33 | 未披露 |
更多>>
From January 1, 2024 to March 31, 2024
Vesting of restricted stock units
Shares withheld related to net share settlement
Issuance of common stock
Exercise of stock options
|
2024-03-31 |
| 2024-02-27 | 40954.17 | 未披露 | 定期报告 | 2024-02-24 |
| 2024-02-27 | 40638.70 | 未披露 |
更多>>
From January 1, 2023 to December 31, 2023
Exercise of stock options
Common stock repurchase
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2023-12-31 |
| 2023-11-02 | 40604.09 | 未披露 | 定期报告 | 2023-10-27 |
| 2023-11-02 | 40598.00 | 未披露 |
更多>>
From July 1, 2023 to September 30, 2023
Vesting of restricted stock units
Shares withheld related to net share settlement
Exercise of stock options
|
2023-09-30 |
| 2023-08-03 | 40548.21 | 未披露 | 定期报告 | 2023-07-31 |
| 2023-08-03 | 40542.70 | 未披露 |
更多>>
From April 1, 2023 to June 30, 2023
Exercise of stock options
Common stock repurchase
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2023-06-30 |
| 2023-05-09 | 41483.30 | 未披露 | 定期报告 | 2023-05-01 |
| 2023-05-09 | 41446.50 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Vesting of restricted stock units
Shares withheld related to net share settlement
Exercise of stock options
|
2023-03-31 |
| 2023-03-01 | 41311.87 | 未披露 | 定期报告 | 2023-02-24 |
| 2023-03-01 | 41238.50 | 未披露 |
更多>>
From January 1, 2022 to December 31, 2022
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2022-12-31 |
| 2022-11-03 | 41185.48 | 未披露 | 定期报告 | 2022-10-31 |
| 2022-11-03 | 41174.10 | 未披露 |
更多>>
From July 1, 2022 to September 30, 2022
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2022-09-30 |
| 2022-08-04 | 41093.64 | 未披露 | 定期报告 | 2022-07-29 |
| 2022-08-04 | 40820.40 | 未披露 |
更多>>
From April 1, 2022 to June 30, 2022
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
|
2022-06-30 |
| 2022-05-05 | 40673.09 | 未披露 | 定期报告 | 2022-04-30 |
| 2022-04-11 | 40568.05 | 未披露 | 定期报告 | 2022-04-01 |
| 2022-05-05 | 40572.70 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Exercise of stock options and other, net
|
2022-03-31 |
| 2022-03-03 | 40117.78 | 未披露 | 定期报告 | 2022-02-15 |
| 2022-03-03 | 40009.50 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Reclassification of contingently redeemable common stock in connection with IPO
Issuance of common stock in connection with IPO net of offering costs
Issuance of common stock under partner physician group equity agreements upon IPO
Exercise of stock options and other, net
|
2021-12-31 |
| 2021-10-28 | 39365.54 | 未披露 | 定期报告 | 2021-10-22 |
| 2021-10-28 | 39154.80 | 未披露 |
更多>>
From July 1, 2021 to September 30, 2021
Exercise of stock options and other, net
|
2021-09-30 |
| 2021-09-14 | 39144.80 | 未披露 |
更多>>
1.Common stock offered by the selling stockholders 17,000,000 shares.
2.The number of shares of common stock to be outstanding immediately following this offering is based on 390,882,560 shares outstanding as of June 30, 2021.
|
2021-09-14 |
| 2021-09-07 | 39088.30 | 未披露 |
更多>>
From April 1, 2021 to June 30, 2021
Reclassification of contingently redeemable common stock in connection with initial public offering ("IPO")
Issuance of common stock in connection with IPO, net of offering costs
Issuance of common stock under partner physician group equity agreements upon IPO
Exercise of stock options and other, net
|
2021-06-30 |
| 2021-05-26 | 39083.26 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-04-19 | 39101.16 | 未披露 |
更多>>
1.On April 15, 2021, the underwriters exercised their option to purchase an additional 6,990,000 shares of Common Stock. On April 19, 2021, the Company’s sale of an aggregate of 53,590,000 shares of Common Stock was completed.
|
2021-04-19 |
| 2021-04-16 | 38402.16 | 未披露 |
更多>>
1.Common stock offered by the company 46,600,000 shares
2.The number of shares of common stock to be outstanding immediately following this offering is based on 325,749,077 shares outstanding as of March 31, 2021
|
2021-04-15 |
a 1-for-25 reverse stock split of the Company's common stock
From December 31, 2024 to December 31, 2025
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
From July 1, 2025 to September 30, 2025
Vesting of restricted stock units
Shares withheld related to net share settlement
From April 1, 2025 to June 30, 2025
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
From January 1, 2025 to March 31, 2025
Vesting of restricted stock units
Shares withheld related to net share settlement
From December 31, 2023 to December 31, 2024
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
Issuance of common stock
From July 1, 2024 to September 30, 2024
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
From April 1, 2024 to June 30, 2024
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
From January 1, 2024 to March 31, 2024
Vesting of restricted stock units
Shares withheld related to net share settlement
Issuance of common stock
Exercise of stock options
From January 1, 2023 to December 31, 2023
Exercise of stock options
Common stock repurchase
Vesting of restricted stock units
Shares withheld related to net share settlement
From July 1, 2023 to September 30, 2023
Vesting of restricted stock units
Shares withheld related to net share settlement
Exercise of stock options
From April 1, 2023 to June 30, 2023
Exercise of stock options
Common stock repurchase
Vesting of restricted stock units
Shares withheld related to net share settlement
From January 1, 2023 to March 31, 2023
Vesting of restricted stock units
Shares withheld related to net share settlement
Exercise of stock options
From January 1, 2022 to December 31, 2022
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
From July 1, 2022 to September 30, 2022
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
From April 1, 2022 to June 30, 2022
Exercise of stock options
Vesting of restricted stock units
Shares withheld related to net share settlement
From January 1, 2022 to March 31, 2022
Exercise of stock options and other, net
From January 1, 2021 to December 31, 2021
Reclassification of contingently redeemable common stock in connection with IPO
Issuance of common stock in connection with IPO net of offering costs
Issuance of common stock under partner physician group equity agreements upon IPO
Exercise of stock options and other, net
From July 1, 2021 to September 30, 2021
Exercise of stock options and other, net
1.Common stock offered by the selling stockholders 17,000,000 shares.
2.The number of shares of common stock to be outstanding immediately following this offering is based on 390,882,560 shares outstanding as of June 30, 2021.
From April 1, 2021 to June 30, 2021
Reclassification of contingently redeemable common stock in connection with initial public offering ("IPO")
Issuance of common stock in connection with IPO, net of offering costs
Issuance of common stock under partner physician group equity agreements upon IPO
Exercise of stock options and other, net
1.On April 15, 2021, the underwriters exercised their option to purchase an additional 6,990,000 shares of Common Stock. On April 19, 2021, the Company’s sale of an aggregate of 53,590,000 shares of Common Stock was completed.
1.Common stock offered by the company 46,600,000 shares
2.The number of shares of common stock to be outstanding immediately following this offering is based on 325,749,077 shares outstanding as of March 31, 2021